T1D-CATCH Program for Type 1 Diabetes in Young Adults
(T1DTechCHW Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help young adults from underrepresented minority groups manage type 1 diabetes more effectively. It tests a new approach where community health workers (CHWs) support and encourage the use of diabetes technology. Participants will either receive this support or continue with their usual care. Ideal candidates are 18-35 years old, identify as non-Hispanic Black or Hispanic, have had type 1 diabetes for at least six months, and are not currently using connected diabetes technology. As an unphased trial, this study provides a unique opportunity to contribute to innovative diabetes care strategies and potentially improve personal health management.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on encouraging the use of diabetes technology, so it's best to ask the study team for more details.
What prior data suggests that the T1D-CATCH model is safe for young adults with type 1 diabetes?
Research has shown that programs like T1D-CATCH, which use community health workers (CHWs), are generally safe for participants. Studies have found that CHWs help people manage their health better without causing harm. Similar programs have reported no serious side effects. CHWs receive training to support people, especially those at higher risk, by providing education and guidance. This approach has been well-received and may improve health without introducing new risks.12345
Why are researchers excited about this trial?
Researchers are excited about the T1D-CATCH Program because it offers a fresh approach by using Community Health Workers (CHWs) to provide personalized and peer-supported care for young adults with Type 1 Diabetes. Unlike the usual care, which primarily involves routine visits to healthcare providers for monitoring and treatment adjustments, this program emphasizes technology education and social support through both individual and group sessions. The flexibility of videoconferencing or in-person meetings, depending on participant preference and COVID-19 guidelines, adds a modern twist that could improve engagement and outcomes for young adults managing their diabetes.
What evidence suggests that the T1D-CATCH program is effective for young adults with type 1 diabetes?
Research shows that community health workers (CHWs) can help young adults from minority groups with type 1 diabetes (T1D) overcome challenges in using diabetes technology. Studies have found that CHWs provide essential education and support, facilitating the adoption and continued use of these tools. This approach is cost-effective and scalable to assist more individuals. Previous research has demonstrated that CHWs have successfully increased technology use, which is crucial for managing T1D. In this trial, the T1D-CATCH program, which participants may receive, specifically aims to boost technology use in these groups, showing promise in improving diabetes care.12346
Who Is on the Research Team?
Shivani Agarwal, MD
Principal Investigator
Albert Einstein College of Medicine
Are You a Good Fit for This Trial?
This trial is for young adults aged 18-30 with type 1 diabetes who are not currently using a connected diabetes technology system. Participants must be from underrepresented minority groups, specifically non-Hispanic Black or Hispanic, and speak English or Spanish. Those who are pregnant, have disabilities that interfere with participation, or have been in another related study recently cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the T1D-CATCH intervention or usual care over a 9-month period, with weekly individual sessions and optional monthly group sessions for the intervention group.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with assessments of autonomy, competence, social support, and quality of life.
What Are the Treatments Tested in This Trial?
Interventions
- Community Health Worker
- T1D-CATCH
Community Health Worker is already approved in United States for the following indications:
- Support for diabetes technology use in type 1 diabetes
Find a Clinic Near You
Who Is Running the Clinical Trial?
Albert Einstein College of Medicine
Lead Sponsor
The Leona M. and Harry B. Helmsley Charitable Trust
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator